#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	742	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1082	36.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	307	309	ACG	32;32;32	A;C;G	32;32;32	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	A888G	SNP	888	888	A	10	10	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	C897G	SNP	897	897	C	19	19	G	18	G	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	T898C	SNP	898	898	T	20	20	C	20	C	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	G906T	SNP	906	906	G	28	28	T	27	T	26	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	G908A	SNP	908	908	G	30	30	A	28	A	28	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	A918T	SNP	918	918	A	40	40	T	30	T	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	A943G	SNP	943	943	A	65	65	G	69	G	69	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	454	Chlamydophila_psittaci_16S	1507	119	92.44	Chlamydophila_psittaci_16S.l15.c17.ctg.1	127	37.5	0	.	n	.	0	G991T	SNP	991	991	G	113	113	T	49	T	49	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	L121Q	0	.	.	361	363	CTG	359	361	CTG	121;119;117	C;T;G	120;117;115	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Q125E	0	.	.	373	375	CAG	371	373	CAG	122;123;125	C;A;G	121;121;123	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Q125R	0	.	.	373	375	CAG	371	373	CAG	122;123;125	C;A;G	121;121;123	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Q125K	0	.	.	373	375	CAG	371	373	CAG	122;123;125	C;A;G	121;121;123	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Y161N	0	.	.	481	483	TAC	479	481	TAC	157;152;154	T;A;C,A	155;151;153,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Y161C	0	.	.	481	483	TAC	479	481	TAC	157;152;154	T;A;C,A	155;151;153,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	Y161D	0	.	.	481	483	TAC	479	481	TAC	157;152;154	T;A;C,A	155;151;153,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	G317D	0	.	.	949	951	GGC	947	949	GGC	165;165;163	G;G,T;C	165;162,1;163	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1124	1126	GCA	80;79;81	G,A;C;A	77,1;73;81	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1124	1126	GCA	80;79;81	G,A;C;A	77,1;73;81	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1133	1135	GAA	73;73;75	G;A;A	72;73;74	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	0	HET	.	.	.	C99T	.	99	99	C	97	97	C	73	C,T	46,27	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	0	HET	.	.	.	C954T	.	954	954	C	952	952	C	147	C,T	69,78	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	0	HET	.	.	.	T135C	.	135	135	T	133	133	T	77	T,C	47,22	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	1164	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1164	116.2	0	HET	.	.	.	C216T	.	216	216	C	214	214	C	100	C,T	63,37	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	69	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	191	17.8	1	SNP	p	A376V	0	.	.	1126	1128	GCA	10	12	GCA	9;9;10	G;C;A	3;3;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	69	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	191	17.8	1	SNP	p	A376S	0	.	.	1126	1128	GCA	10	12	GCA	9;9;10	G;C;A	3;3;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	2874	Escherichia_coli_EF_Tu	1185	69	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	191	17.8	1	SNP	p	E379K	0	.	.	1135	1137	GAA	19	21	GAA	11;11;12	G;A;A	5;5;6	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1354	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1804	40.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1242	1244	GAA	41;41;41	G;A;A	41;41;41	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	280	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	870	17.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	164	G	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	167	T	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	280	G	278	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	269	C	268	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	248	C	248	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	189	T	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	195	C	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	179	C	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	186	A	186	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	183	A	183	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	191	A	191	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	181	T	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	176	C	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	165	C	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	166	A,G	165,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	172	G	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	171	C	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	189	T	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	235	G	234	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	254	G	253	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	258	T	258	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	209	T	209	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	201	G	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	170	C	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	155	A	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	106	C	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	99	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	5	A	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	4	G	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	80	T	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	101	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	100	T	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	193	C	192	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	3986	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	560	192.6	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	144	C,T	74,41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1016	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1554	35.1	0	.	p	.	0	H2R	NONSYN	4	6	CAT	255	257	CGT	29;31;32	C;G;T	28;30;32	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1016	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1554	35.1	0	.	p	.	0	V30I	NONSYN	88	90	GTC	339	341	ATC	33;33;33	A;T;C	33;33;33	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1016	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1554	35.1	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1098	1100	GGC	53;52;49	G;G;C	53;52;49	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1510	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2068	39.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	237	239	AGC	23;21;21	A;G;C	23;21;21	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1510	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2068	39.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	639	641	CTA	36;35;35	C;T;A	36;35;35	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1510	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2068	39.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1158	1160	CAA	60;61;59	C;A;A	60;61;59	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1510	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2068	39.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1257	1259	GGT	64;62;62	G;G;T	64;62;62	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1510	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2068	39.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1827	1829	GTT	17;16;14	G;T;T	17;16;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	626	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1444	23.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	574	576	GAA	24;24;22	G;A;A	24;24;22	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	626	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1444	23.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	754	756	ACC	9;9;9	A;C;C	9;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	626	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1444	23.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	874	876	ACT	21;20;19	A;C;T	21;20;19	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	626	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1444	23.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1264	1266	ATC	14;14;15	A;T;C	13;14;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2516	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3498	38.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	475	477	ATC	25;25;25	A;T;C	25;25;25	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2516	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3498	38.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2188	2190	AAG	29;29;28	A;A;G	29;28;28	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1132	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1606	38.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	278	280	GTC	19;18;19	G;T;C	19;18;19	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1132	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1606	38.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1019	1021	TGC	58;58;57	T;G;C	58;58;57	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2642	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2844	49.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	179	179	T	23	T	23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2642	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2844	49.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	485	487	GAC	58;59;56	G;A,T;C	58;55,1;56	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2642	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2844	49.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	761	763	TTA	25;25;25	T;T;A,T	25;25;23,1	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2642	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2844	49.0	0	.	p	.	0	D301N	NONSYN	901	903	GAT	944	946	AAT	34;37;37	A;A;T	34;37;35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2642	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	2844	49.0	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1731	1731	T	42	T	42	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	730	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1083	36.2	1	SNP	p	R45C	0	.	.	133	135	CGC	337	339	CGC	65;64;63	C;G;C	65;64;63	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	578	acrS	663	663	98.64	acrS.l15.c17.ctg.1	951	32.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	154	156	TTC	34;34;34	T;T;C	34;34;34	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	578	acrS	663	663	98.64	acrS.l15.c17.ctg.1	951	32.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	418	420	GGG	40;39;38	G;G;G	40;39;38	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	756	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1161	35.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	610	612	CTT	48;47;49	C;T;T	48;46;49	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2660	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3076	46.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2073	2075	GCA	49;51;50	G;C,A;A	49;50,1;50	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2660	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3076	46.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2334	2336	ACC	55;54;54	A;C;C	52;52;53	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2660	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3076	46.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2643	2645	GCC	39;40;41	G;C;C	39;39;41	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	564	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1252	24.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	869	871	ACC	19;18;18	A;C;C	19;18;18	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	564	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1252	24.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	881	883	TCG	25;26;25	T;C;G,A	25;26;24,1	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	378	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1142	17.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	812	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1602	26.5	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1312	1314	AAA	15;15;15	A;A;A	12;14;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	812	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1602	26.5	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1324	1326	GAG	11;12;12	G;A;G	11;12;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	812	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1602	26.5	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1330	1332	CAC	13;13;13	C;A;C	13;13;13	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	812	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1602	26.5	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1384	1386	GAG	17;18;17	G;A;G	17;18;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1270	cpxA	1374	1374	98.91	cpxA.l6.c17.ctg.1	1869	36.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	792	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1178	36.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	734	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1399	28.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	659	661	ACT	33;34;35	A;C;T	32;34;35	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1084	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1673	34.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	926	928	GTC	49;49;48	G;T;C,A	49;49;47,1	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1458	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2054	38.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	894	896	AAA	53;53;52	A;A;A	53;53;52	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	948	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1468	33.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	830	832	AGC	23;23;23	A;G;C	23;23;23	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	42	emrE_1	333	95	96.84	emrE_1.l15.c4.ctg.1	130	7.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	624	emrR	531	531	100.0	emrR.l15.c4.ctg.1	979	34.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	746	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1248	32.1	1	SNP	p	P64H	0	.	.	190	192	CCA	393	395	CCA	47;47;49	C;C;A	47;47;47	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	746	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1248	32.1	1	SNP	p	P64L	0	.	.	190	192	CCA	393	395	CCA	47;47;49	C;C;A	47;47;47	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	746	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1248	32.1	1	SNP	p	P64S	0	.	.	190	192	CCA	393	395	CCA	47;47;49	C;C;A	47;47;47	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	746	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1248	32.1	1	SNP	p	P64A	0	.	.	190	192	CCA	393	395	CCA	47;47;49	C;C;A	47;47;47	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	746	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1248	32.1	1	SNP	p	P64R	0	.	.	190	192	CCA	393	395	CCA	47;47;49	C;C;A	47;47;47	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	632	gadE	528	528	100.0	gadE.l15.c4.ctg.1	952	35.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	160	gadW	729	156	96.79	gadW.l15.c4.ctg.1	156	25.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	160	gadW	729	143	95.8	gadW.l15.c4.ctg.2	143	12.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	12	14	AAT	5;5;5	A;A;T	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	554	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1187	25.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	329	331	TTA	27;26;25	T;T;A	27;26;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	554	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1187	25.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	407	409	ATT	23;23;23	A;T;T	23;23;23	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	554	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1187	25.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	908	910	GGA	20;22;24	G;G,T;A	20;21,1;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	554	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1187	25.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	914	916	CCG	24;24;24	C;C;G	24;24;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2245	2247	GAA	51;50;51	G;A;A	51;50;49	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	S83W	0	.	.	247	249	TCG	460	462	TCG	42;41;41	T;C;G	41;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	S83I	0	.	.	247	249	TCG	460	462	TCG	42;41;41	T;C;G	41;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	S83L	0	.	.	247	249	TCG	460	462	TCG	42;41;41	T;C;G	41;40;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	D87N	0	.	.	259	261	GAC	472	474	GAC	44;44;43	G,T;A;C	41,1;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	D87H	0	.	.	259	261	GAC	472	474	GAC	44;44;43	G,T;A;C	41,1;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	D87Y	0	.	.	259	261	GAC	472	474	GAC	44;44;43	G,T;A;C	41,1;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	D87V	0	.	.	259	261	GAC	472	474	GAC	44;44;43	G,T;A;C	41,1;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2402	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3052	42.4	1	SNP	p	D87G	0	.	.	259	261	GAC	472	474	GAC	44;44;43	G,T;A;C	41,1;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136L	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136C	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136G	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136E	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136S	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136H	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2216	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2819	42.3	1	SNP	p	R136I	0	.	.	406	408	CGC	615	617	CGC	49;50;49	C;G;C	49;50;49	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1081	24.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	417	419	CCG	46;45;47	C;C;G	44;45;47	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1081	24.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	570	572	GCC	33;34;34	G;C;C	33;33;34	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1020	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1365	40.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	219	221	TCA	38;36;39	T;C;A	38;36;39	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	328	marA	384	384	99.74	marA.l15.c30.ctg.1	865	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	507	509	AGC	15;14;13	A;G;C	14;14;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	609	611	CAT	6;5;5	C;A;T	6;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	V45E	0	.	.	133	135	GTG	333	335	GTG	36;35;35	G;T;G	36;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	I49S	0	.	.	145	147	ATC	345	347	ATC	29;29;29	A;T;C	29;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	A70T	0	.	.	208	210	GCA	408	410	GCA	12;12;12	G;C;A	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R73S	0	.	.	217	219	CGT	417	419	CGT	12;12;11	C;G;T	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R73C	0	.	.	217	219	CGT	417	419	CGT	12;12;11	C;G;T	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R77C	0	.	.	229	231	CGC	429	431	CGC	16;16;16	C;G;C	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R77L	0	.	.	229	231	CGC	429	431	CGC	16;16;16	C;G;C	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	L78M	0	.	.	232	234	CTG	432	434	CTG	15;15;15	C;T;G	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R94H	0	.	.	280	282	CGC	480	482	CGC	12;11;12	C;G;C	12;11;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	R94S	0	.	.	280	282	CGC	480	482	CGC	12;11;12	C;G;C	12;11;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	202	marR	435	432	97.69	marR.l15.c30.ctg.1	632	16.3	1	SNP	p	V96E	0	.	.	286	288	GTA	486	488	GTA	12;12;13	G;T;A	12;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	41	43	TTC	5;5;5	T;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	128	130	ATC	10;10;8	A;T;C	10;10;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	146	148	GCC	6;6;6	G;C;C	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	149	151	GTG	6;6;6	G;T;G	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	176	178	GAT	11;11;11	G;A;T	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	197	199	ACC	11;11;11	A;C;C	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	224	226	TTA	12;12;14	T;T;A	12;12;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	365	367	CAG	31;29;29	C;A;G	31;28;28	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	404	406	GCC	31;30;32	G;C;C	31;30;32	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	509	511	GCG	21;20;19	G;C;G	21;20;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	713	715	GTT	21;21;21	G,T;T;T	15,1;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	652	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1372	24.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	875	875	C	18	C	18	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	34	34	G	23	G	23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	91	93	CAG	12;12;11	C;A;G	12;12;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	T83I	NONSYN	247	249	ACC	241	243	ATC	15;15;14	A;T;C	15;15;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	I99M	NONSYN	295	297	ATA	289	291	ATG	7;7;8	A;T;G	7;7;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	A130T	NONSYN	388	390	GCC	382	384	ACC	12;11;12	A;C;C	12;11;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	608	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1433	21.8	0	.	p	.	0	P257T	NONSYN	769	771	CCG	763	765	ACG	18;18;18	A;C;G	18;18;18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1939	1941	ACC	40;44;46	A;C;C	40;44;46	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2332	2334	CAA	19;18;18	C;A;A	19;18;18	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2500	2502	ATT	14;15;14	A;T;T	14;15;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2584	2586	GTT	36;36;37	G;T;T	36;36;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2692	2694	GAG	24;25;23	G;A;G	24;25;23	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2920	2922	ATG	21;21;20	A;T;G	21;21;20	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2108	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3406	33.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3055	3057	GAT	31;31;31	G;A;T	30;30;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1914	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3346	30.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	385	387	ATG	16;16;17	A;T;G	16;16;17	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1914	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3346	30.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	871	873	ATC	41;42;43	A;T;C	40;42;43	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1914	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3346	30.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3187	3189	CAC	5;5;5	C;A;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1914	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3346	30.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3190	3192	CTC	5;5;4	C;T;C	5;5;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	858	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	25.2	0	.	p	.	0	D3E	NONSYN	7	9	GAT	196	198	GAA	5;5;5	G;A;A	5;5;5	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	858	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	25.2	0	.	p	.	0	T226A	NONSYN	676	678	ACG	865	867	GCG	21;20;19	G;C;G	21;20;19	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	858	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	25.2	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1207	1209	ATC	28;28;30	A;T;C	28;27;30	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	858	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1828	25.2	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1510	1512	TTT	38;38;38	T;T;T	38;38;38	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1266	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1625	41.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3070	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3549	46.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1111	1113	ACC	47;49;52	A;C,A;C	46;40,2;52	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3070	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3549	46.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2353	2355	GAC	48;49;49	G;A;C	47;49;47	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	994	mdtG	1227	177	99.44	mdtG.l15.c17.ctg.1	187	19.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	4;5;5	G;G;A	4;5;5	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	994	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.2	1460	31.5	0	.	p	.	0	V200I	NONSYN	598	600	GTC	610	612	ATC	30;30;31	A;T;C	30;30;31	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	790	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1570	27.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	601	603	TGT	38;39;40	T;G;T	38;39;40	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	790	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1570	27.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1171	1173	TTG	26;25;26	T;T;G	26;24;26	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	790	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1570	27.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1381	1383	ACG	9;9;9	A;C;G	9;9;9	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1076	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1622	35.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	779	781	TCC	28;29;31	T;C;C	27;29;31	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	716	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1469	26.1	0	.	p	.	0	V119I	NONSYN	355	357	GTT	577	579	ATT	21;21;22	A;T;T	20;21;22	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	190	192	ATG	14;14;14	A;T;G	14;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	256	258	ATC	19;21;21	A;T;C	18;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	505	507	CGC	42;41;40	C;G;C	42;41;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	871	873	AGC	40;40;41	A;G;C	40;40;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1072	1074	GTG	32;32;31	G;T;G	32;32;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1135	1137	AAC	13;12;12	A;A;C	13;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1180	1182	GTC	24;24;25	G;T;C	24;23;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1210	1212	ATA	42;41;41	A;T;A	42;41;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1318	1320	TCT	37;37;37	T;C;T	37;37;37	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1705	1707	GCG	43;43;42	G;C;G	42;42;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1514	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2417	33.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1918	1920	ATC	37;37;38	A;T;C	37;37;38	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	592	594	GCG	29;31;32	G;C;G	28;31;32	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	766	768	ACC	27;29;30	A;C;C	27;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	838	840	CGC	34;35;35	C;G;C	34;35;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	955	957	GCT	38;38;36	G;C;T	37;37;35	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1039	1041	AAA	20;20;21	A;A;A	19;20;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1057	1059	CGA	24;24;24	C;G;A	24;24;24	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1222	1224	GCC	23;23;25	G;C;C	23;23;25	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1234	1236	GAT	29;30;30	G;A;T	29;30;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1064	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1850	30.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1651	1653	GCT	12;12;12	G;C;T	12;12;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2536	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3926	34.8	0	.	p	.	0	A278S	NONSYN	832	834	GCC	1108	1110	TCC	46;45;45	T,G;C;C	45,1;45;44	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2536	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3926	34.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1585	1587	AAG	26;23;24	A;A;G	26;23;24	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2536	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3926	34.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2662	2664	CTG	33;32;33	C;T;G	32;31;33	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	178	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	167	28.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1742	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2137	43.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1010	1012	AAC	46;45;44	A;A;C	46;45;44	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1742	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2137	43.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1556	1558	ATA	49;50;49	A;T;A	49;49;49	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1348	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1749	41.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1367	1369	GAT	61;62;59	G;A;T	59;59;58	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1348	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1749	41.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1370	1372	CTG	61;61;62	C;T;G	60;60;61	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	299	301	TGT	27;29;30	T;G;T	26;29;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	569	571	ACC	27;27;26	A;C;C	27;27;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	779	781	GAC	25;25;24	G;A;C	25;25;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	1	SNP	p	R15C	0	.	.	43	45	CGC	263	265	CGC	39;39;40	C;G;C	39;39;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	1	SNP	p	S33R	0	.	.	97	99	AGC	317	319	AGC	26;26;25	A;G;C	26;26;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	1	SNP	p	G131D	0	.	.	391	393	GGC	611	613	GGC	33;34;36	G;G;C	33;34;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	1	SNP	p	R203L	0	.	.	607	609	CGT	827	829	CGT	29;29;29	C;G;T	29;29;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	504	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1148	23.4	1	SNP	p	R203C	0	.	.	607	609	CGT	827	829	CGT	29;29;29	C;G;T	29;29;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1302	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1565	44.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1187	1189	GAG	58;57;52	G;A;G	58;57;52	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1302	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1565	44.8	1	SNP	p	G141E	0	.	.	421	423	GGT	674	676	GGT	70;70;67	G;G;T	70;70;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1302	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1565	44.8	1	SNP	p	G141D	0	.	.	421	423	GGT	674	676	GGT	70;70;67	G;G;T	70;70;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1302	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1565	44.8	1	SNP	p	R154A	0	.	.	460	462	CGT	713	715	CGT	59;61;61	C;G;T	59;60;60	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1302	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1565	44.8	1	SNP	p	R154D	0	.	.	460	462	CGT	713	715	CGT	59;61;61	C;G;T	59;60;60	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1913	1915	GTG	64;64;63	G;T,C;G	64;62,2;63	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1940	1942	TCG	62;62;60	T;C;G	56;58;57	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2555	2557	AAC	35;35;36	A;A;C	35;34;36	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	1	SNP	p	A85T	0	.	.	253	255	GCG	569	571	GCG	44;45;47	G;C;G	41;44;44	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	1	SNP	p	D111H	0	.	.	331	333	GAT	647	649	GAT	37;40;40	G;A;T	37;39;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2380	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2789	45.9	1	SNP	p	S129P	0	.	.	385	387	TCC	701	703	TCC	60;58;61	T;C;C	60;58;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1478	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2390	33.3	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1643	1645	AAC	47;45;46	A;A;C	47;45;46	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1478	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2390	33.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1652	1654	GAT	46;47;45	G;A;T	46;47;45	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1252	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1817	37.1	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	829	831	CAG	32;32;34	C;A;G	32;32;34	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1252	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1817	37.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1303	1305	GAT	46;45;43	G;A;T	46;43;43	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	V146F	0	.	.	436	438	GTT	628	630	GTT	61;61;61	G;T;T	61;61;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1729	1731	CAG	73;71;69	C;A;G	73;71;69	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1729	1731	CAG	73;71;69	C;A;G	73;71;69	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1768	1770	CAC	42;42;41	C;A;C	42;42;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1777	1779	CGT	43;40;37	C;G;T	43;40;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1777	1779	CGT	43;40;37	C;G;T	43;40;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1783	1785	TCC	34;35;34	T;C;C	34;35;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1789	1791	CTC	32;32;32	C;T;C	32;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1879	1881	ACC	60;60;61	A;C;C	60;60;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1882	1884	CCT	61;60;61	C;C;T	61;60;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4462	rpoB	4029	4029	99.03	rpoB.l15.c17.ctg.1	4466	53.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2251	2253	CGT	80;76;76	C;G;T	80;76;75	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	.	n	.	0	A226G	SNP	226	226	A	344	344	G	423	G	422	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	.	n	.	0	C719T	SNP	719	719	C	837	837	T	293	T,C	145,148	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	A794G	0	.	.	794	794	A	912	912	A	336	A,G	328,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	A794T	0	.	.	794	794	A	912	912	A	336	A,G	328,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	G926C	0	.	.	926	926	G	1044	1044	G	332	G	329	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	G926T	0	.	.	926	926	G	1044	1044	G	332	G	329	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	G926A	0	.	.	926	926	G	1044	1044	G	332	G	329	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	1637	1637	A	279	A	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	1637	1637	A	279	A	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	1637	1637	A	279	A	277	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	G1006C	.	1006	1006	G	1124	1124	G	350	G,C	201,144	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	A79G	.	79	79	A	197	197	A	306	A,G	221,82	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	T273A	.	273	273	T	391	391	T	323	T,A	225,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	T1010C	.	1010	1010	T	1128	1128	T	362	T,C	208,144	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	C1038T	.	1038	1038	C	1156	1156	C	341	C,T	210,130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	C183T	.	183	183	C	301	301	C	324	C,T	228,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	A250T	.	250	250	A	368	368	A	370	A,T	265,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	T90C	.	90	90	T	208	208	T	295	T,C	220,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	G474A	.	474	474	G	592	592	G	387	G,A	295,92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	A253T	.	253	253	A	371	371	A	366	A,T	261,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	C194T	.	194	194	C	312	312	C	350	C,T	269,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	11674	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.1	1673	348.8	0	HET	.	.	.	G1002A	.	1002	1002	G	1120	1120	G	355	G,A	205,149	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	508	soxR	465	465	100.0	soxR.l15.c4.ctg.1	866	31.4	1	SNP	p	R20H	0	.	.	58	60	CGC	235	237	CGC	44;44;44	C;G;C	44;44;44	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	508	soxR	465	465	100.0	soxR.l15.c4.ctg.1	866	31.4	1	SNP	p	G121D	0	.	.	361	363	GGT	538	540	GGT	36;37;38	G;G;T	36;37;38	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	378	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	768	26.5	1	SNP	p	A12S	0	.	.	34	36	GCA	243	245	GCA	40;40;39	G;C;A	40;40;39	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	539	1422	tolC	1488	1488	98.66	tolC.l15.c4.ctg.1	1921	39.8	0	.	p	.	0	G67S	NONSYN	199	201	GGT	406	408	AGT	41;41;41	A,G;G;T	40,1;41;41	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
